e-learning
resources
London 2016
Sunday, 04.09.2016
Pulmonary drug delivery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Initial interaction of fluticasone propionate with ciliated respiratory epithelium
Dani Do Hyang Lee (London, United Kingdom), Dani Do Hyang Lee, Priya Radhakrishnan, Claire M. Smith, Chris O’Callaghan
Source:
International Congress 2016 – Pulmonary drug delivery
Session:
Pulmonary drug delivery
Session type:
Thematic Poster
Number:
975
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dani Do Hyang Lee (London, United Kingdom), Dani Do Hyang Lee, Priya Radhakrishnan, Claire M. Smith, Chris O’Callaghan. Initial interaction of fluticasone propionate with ciliated respiratory epithelium. Eur Respir J 2016; 48: Suppl. 60, 975
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Fluticasone propionate reduces bacterial airway epithelial invasion
Source: Eur Respir J 2008; 32: 1283-1288
Year: 2008
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Corticosteroid plus long-acting beta
2
-agonist prevent virus-associated upregulation of B7-H1/PD-L1 on airway epithelium
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Comparative anti-oxidant effects of carbocysteine and fluticasone propionate in cigarette smoke stimulated airway epithelial cells
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Budesonide esterification in human bronchial epithelial cells is not impaired by formoterol
Source: Eur Respir J 2002; 20: Suppl. 38, 619s
Year: 2002
Budesonide and fluticasone propionate exertdifferential effects on human bronchial epithelial cells exposed to streptococcus pneumoniae and viral mimetic
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Anti-inflammatory effect of the combination of a long acting beta2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following
Staphylococcus aureus
infection
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
Role of budesonide, formoterol fumarate and aclidinium bromide in the inflammaging of airway epithelial cells
Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Year: 2017
Nasal fibroblast functions involved in airway inflammation and remodelling are downregulated by fluticasone propionate (FP)
Source: Eur Respir J 2001; 18: Suppl. 33, 147s
Year: 2001
Additive blockade of β2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate
Source: Eur Respir J 2004; 23: 511-517
Year: 2004
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
Inhibitory activities of fluticasone propionate and salmeterol on airway epithelial cell functions (FLIC24): adhesion molecule expression and cytokine release
Source: Eur Respir J 2001; 18: Suppl. 33, 246s
Year: 2001
Proliferation is not increased in airway myofibroblasts isolated from asthmatics
Source: Eur Respir J 2008; 32: 362-371
Year: 2008
Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept